Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

计划入组 1,500 人 · 首次发布于 2026 年 2 月 2 日

A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants

计划入组 133 人 · 首次发布于 2024 年 12 月 12 日

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

计划入组 472 人 · 首次发布于 2026 年 7 月 7 日

Trospium Chloride/Xanomeline

Xanomeline Tartrate and Trospium Chloride

Xanomeline

C₁₄H₂₃N₃OS

Harbin Medisan Pharmaceutical Co., Ltd .

Hubei Heyuan Gas Co.,Ltd.

Hunan Nucien Pharmaceutical Co., Ltd.

Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment

Xanomeline/Trospium Chloride Shows Cognitive Improvement in Schizophrenia; MindMed's LSD Trial Begins

Xanomeline-Trospium Shows Consistent Efficacy in Schizophrenia Across Pooled Phase 3 Trials